|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.50 INR | +1.49% |
|
+5.81% | +7.40% |
Company Valuation: Vineet Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 439.3 | 381.7 | 446.2 | 287.6 |
| Change | - | -13.12% | 16.91% | -35.54% |
| Enterprise Value (EV) 1 | 523.3 | 686.2 | 886.9 | 685 |
| Change | - | 31.15% | 29.24% | -22.76% |
| P/E | 6.62x | 30.5x | 43.6x | -1.42x |
| PBR | 1.32x | 1.13x | 1.28x | 1.96x |
| PEG | 0x | -0.4x | -2.4x | 0x |
| Capitalization / Revenue | 229,785x | 179,783x | 295,567x | 373,778x |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | - | - | - | - |
| EV / EBIT | 4.66x | 12.2x | 17.5x | -4.07x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | 1 | - | - | - |
| Rate of return | 2.1% | - | - | - |
| EPS 2 | 7.201 | 1.359 | 1.11 | -21.9 |
| Distribution rate | 13.9% | - | - | - |
| Net sales | 1,912 | 2,123 | 1,510 | 769.5 |
| EBITDA | 132.4 | 79.97 | 74.27 | -143.3 |
| EBIT 1 | 112.3 | 56.24 | 50.54 | -168.3 |
| Net income 1 | 66.39 | 12.52 | 10.27 | -201.9 |
| Net Debt 1 | 83.97 | 304.6 | 440.7 | 397.4 |
| Reference price 2 | 47.65 | 41.40 | 48.40 | 31.20 |
| Nbr of stocks (in thousands) | 9,219 | 9,219 | 9,219 | 9,219 |
| Announcement Date | 5/9/22 | 5/9/23 | 4/9/24 | 2/9/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 7.82M | ||
| 36.25x | 12.94x | 27.18x | 0.55% | 1,089B | ||
| 28.59x | 6.53x | 18.09x | 2.01% | 643B | ||
| 33.13x | 7.75x | 15.94x | 2.61% | 465B | ||
| 20.2x | 4.86x | 12.04x | 2.72% | 359B | ||
| 22.65x | 5.84x | 14.57x | 2.74% | 303B | ||
| 22.03x | 4.53x | 12.8x | 1.93% | 267B | ||
| 14.79x | 5.48x | 11.3x | 3.38% | 226B | ||
| 25.81x | 6.73x | 11.86x | 2.57% | 212B | ||
| -48.4x | 5.8x | 32.01x | 2.45% | 167B | ||
| Average | 17.23x | 6.72x | 17.31x | 2.33% | 373.11B | |
| Weighted average by Cap. | 25.20x | 8.11x | 19.08x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VINEETLAB Stock
- Valuation Vineet Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















